Advertisement

Topics

Avalon Pharmaceuticals Company Profile

18:31 EST 11th December 2018 | BioPortfolio

Avalon Pharmaceuticals' primary mission is to discover and develop innovative small molecule therapeutics using cutting-edge genomic technologies. Through its comprehensive genomics approach, Avalon is able to pinpoint proprietary drug activity markers and drug targets and to use these for drug screening in complex biological systems, facilitating the identification of lead drug candidates. Avalon is developing these drug candidates both internally and through partnerships within the pharmaceutical industry.

By attracting a leading team of innovative scientists and drug discovery experts, utilizing cutting-edge genomics tools, and forming strategic alliances within the industry, Avalon is significantly decreasing the time it takes to develop novel drug therapies to treat deseases. Within the Company's first two-years, Avalon scientists were able to use their novel genomic discovery and screening approaches to identify several small molecule drug candidates for the treatment of cancer.



Avalon identifies small molecule therapeutic compounds directly from genomics data in three steps:



Identification of novel and key proprietary drug activity markers using a comprehensive set of genomics tools including molecular and pathological characterization, cytogenetics, and high density gene expression arrays,

Screening for new small molecule therapeutic compounds using its proprietary methods such as the Company's multi-parameter assays, and

Optimization of lead compounds using cutting-edge medicinal chemistry.

The company's initial therapeutic focus area is solid tumors including cancers of colon, breast, lung, and prostate.



Avalon's strategy of combining the latest genomic approaches for gene and target identification with an aggressive pursuit of small molecule drug discovery has attracted significant interest from the pharmaceutical industry. In order to quickly pursue large-scale discovery and drug development within particular disease areas, Avalon enters partnerships with pharmaceutical companies as well as collaborative agreements with clinical and academic institutions.

Location

20358 Seneca Meadows Parkway
Germantown
20876
United States of America

Contact

Phone: 301-556-1000
Fax: 301-556-1100
Email: info@avalonrx.com


News Articles [342 Associated News Articles listed on BioPortfolio]

Athenex and Avalon HepaPOC pen deal for liver function tests

Avalon HepaPOC Ltd. granted Athenex Inc. exclusive rights to use and sell tests to measure galactose levels in patients using Athenex’s cancer drugs. Avalon HepaPOC is a division of Avalon Biomedica...

Athenex licenses pegylated arginase from Polytom

Avalon Polytom (HK) Ltd., a division of Avalon Biomedical and affiliate of Avalon Global Holdings Ltd., granted Athenex Inc. exclusive global rights to develop and sell therapeutics containing pegtoma...

Philips secures CE mark for new Avalon obstetrical care solution

The new Avalon system has been developed for continuous fetal and maternal monitoring, which automatically streams patient data to the EMR via Philips obstetrical information management system, known ...

GSK & Avalon Ventures: Collaborating to invest $495 million in early stage life science companies

In this episode of PharmaTelevision News Review, filmed at Bio Conference 2013, in Chicago, USA, Fintan Walton talks to Jay Lichter of Avalon Ventures & Lon Cardon of GSK.

Avalon GloboCare Announces Listing on NASDAQ Capital Market

FREEHOLD, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced its common stock ha...

Avalon GloboCare Provides Third Quarter 2018 Business Update; Reports 30% Increase in Revenues

FREEHOLD, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies, today announced financial results and provided a busi...

Avalon GloboCare Provides Second Quarter 2018 Business Update; Reports 32% Increase in Revenues

FREEHOLD, N.J., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, today announced financial results and provided a busin...

Avalon GloboCare Announces Grand Opening of Newly Renovated Headquarters in New Jersey

FREEHOLD, N.J., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies and therapeutics, announced today the grand opening of...

PubMed Articles [134 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Hemodynamic Evaluation of Avalon Elite Bi-Caval Dual Lumen Cannulas and Femoral Arterial Cannulas.

Translational research is a useful tool to provide scientific evidence for cannula selection during extracorporeal life support (ECLS). The objective of this study was to evaluate four Avalon Elite bi...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Clinical Trials [229 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1344 Associated Companies listed on BioPortfolio]

Avalon Pharmaceuticals

Avalon Pharmaceuticals' primary mission is to discover and develop innovative small molecule therapeutics using cutting-edge genomic technologies. Through its comprehensive genomics approach, Avalon i...

Fortis Therapeutics, Inc.

Fortis Therapeutics is an immuno-oncology biotech developing a novel antibody-drug conjugate for late-stage multiple myeloma and metastatic castration-resistant prostate cancer. F...

Avalon Instruments

The Avalon's range of Raman Analyzers offer you High Performance Raman Spectoscopy. Our cutting edge detection, sampling technology, automated calibration and pinned-in-place optics coupled with our i...

Avalon Network NV

Avalon Network helps you to realise re-engineering benefits trough information technology. Our multi-level approach makes our projects Human-centered Result-oriented Technologically reliable We team u...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Avalon Pharmaceuticals" on BioPortfolio

We have published hundreds of Avalon Pharmaceuticals news stories on BioPortfolio along with dozens of Avalon Pharmaceuticals Clinical Trials and PubMed Articles about Avalon Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avalon Pharmaceuticals Companies in our database. You can also find out about relevant Avalon Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record